Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Cytosorbents Cor (CTSO)

Cytosorbents Cor (CTSO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,890
  • Shares Outstanding, K 43,636
  • Annual Sales, $ 43,170 K
  • Annual Income, $ -24,560 K
  • 60-Month Beta 0.71
  • Price/Sales 1.49
  • Price/Cash Flow N/A
  • Price/Book 1.64
Trade CTSO with:

Options Overview Details

View History
  • Implied Volatility 137.58% ( +41.10%)
  • Historical Volatility 91.62%
  • IV Percentile 71%
  • IV Rank 9.95%
  • IV High 1,271.59% on 09/08/22
  • IV Low 12.23% on 01/26/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 1,288

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.18
  • Number of Estimates 3
  • High Estimate -0.13
  • Low Estimate -0.24
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2900 +17.05%
on 11/22/22
2.0500 -26.34%
on 11/03/22
-0.1900 (-11.18%)
since 10/25/22
3-Month
1.1800 +27.97%
on 09/26/22
2.1072 -28.34%
on 08/26/22
-0.5600 (-27.05%)
since 08/25/22
52-Week
1.1800 +27.97%
on 09/26/22
5.4000 -72.04%
on 12/09/21
-3.5100 (-69.92%)
since 11/24/21

Most Recent Stories

More News
CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
CytoSorbents (CTSO) Reports Q3 Loss, Misses Revenue Estimates

CytoSorbents (CTSO) delivered earnings and revenue surprises of -75% and 9.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CTSO : 1.5100 (+2.72%)
QTRX : 11.75 (-0.34%)
CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
CytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
CytoSorbents to Present at the H.C. Wainwright 24th Annual Global Investment Conference

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)
Turkish Ministry of Health Grants National Reimbursement to CytoSorb®

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CTSO : 1.5100 (+2.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product...

See More

Key Turning Points

3rd Resistance Point 1.6067
2nd Resistance Point 1.5633
1st Resistance Point 1.5367
Last Price 1.5100
1st Support Level 1.4667
2nd Support Level 1.4233
3rd Support Level 1.3967

See More

52-Week High 5.4000
Fibonacci 61.8% 3.7880
Fibonacci 50% 3.2900
Fibonacci 38.2% 2.7920
Last Price 1.5100
52-Week Low 1.1800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar